Category: Uncategorized

May 27 2020

Uncategorized

Alkermes Highlights New Data From Schizophrenia Portfolio at the American Society of Clinical Psychopharmacology 2020 Annual Meeting

by Clinical Editor

No Comments

PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced plans to present new research from its schizophrenia portfolio at the American Society of …

May 27 2020

Uncategorized

Schizophrenia: when the thalamus misleads the ear

by Clinical Editor

No Comments

There is an extremely high probability that individuals with 22q11.2 micro deletion syndrome—a rare genetic disorder—will develop schizophrenia together with one of its most common symptoms, auditory …

May 26 2020

Uncategorized

Depression to schizophrenia: Movement-based yoga can significantly improve mental health amid pandemic

by Clinical Editor

No Comments

Movement-based yoga can significantly reduce depressive symptoms in people during the ongoing coronavirus crisis, according to Australian researchers.

May 26 2020

Uncategorized

Why Being ‘High-Functioning’ With Schizophrenia Doesn’t Mean I’m Symptom-Free

by Clinical Editor

No Comments

The writer explains that as someone who is considered to have high-functioning schizophrenia, she still experiences some symptoms and needs support from loved ones.

May 26 2020

Uncategorized

Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies

by Clinical Editor

No Comments

Over the past 25 years, studies analyzing post-mortem brain samples have found evidence of aberrant glycosylation in individuals with schizophrenia. Proteins involved in both excitatory and inhibitory …

May 26 2020

Uncategorized

Gene variants can increase risk of schizophrenia, shows study

by Clinical Editor

No Comments

Variants in a gene of the human immune system cause men and women to have different vulnerabilities to the autoimmune diseases lupus and Sjögren’s syndrome, according to findings published in...

May 26 2020

Uncategorized

Journal of Clinical Psychiatry Publishes Data from Alkermes’ ALPINE Study in Patients With Schizophrenia

by Clinical Editor

No Comments

Alkermes plc (Nasdaq: ALKS) today announced that data from its phase 3b ALPINE (Aripiprazole Lauroxil and Paliperidone palmitate: INitiation Effectiveness) study were published in the Journal of …

May 25 2020

Uncategorized

Journal of Clinical Psychiatry Publishes Data from Alkermes’ ALPINE Study in Patients With Schizophrenia

by Clinical Editor

No Comments

Alkermes plc (Nasdaq: ALKS) today announced that data from its phase 3b ALPINE (Aripiprazole Lauroxil and Paliperidone palmitate: INitiation Effectiveness) study were published in the Journal of …

May 25 2020

Uncategorized

Schizophrenia research foundation to organise online course for journalists

by Clinical Editor

No Comments

Schizophrenia Research Foundation (SCARF), along with a Delhi-based non-governmental organisation Sangath, is organising a 4-week online course on mental health reporting for journalists and …

May 25 2020

Uncategorized

Why Being ‘High-Functioning’ With Schizophrenia Doesn’t Mean I’m Symptom-Free

by Clinical Editor

No Comments

The writer explains that as someone who is considered to have high-functioning schizophrenia, she still experiences some symptoms and needs support from loved ones.